|
Felpreva
|
-
|
EU/2/21/277/010
|
Vetoquinol S.A., Francija
|
QP52AA51
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Tigolaner, Emodepside, Praziquantel
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
11-Nov-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/277/010 |
|
2 |
Polipropilēna aplikators, 1,18 ml |
-
|
|
|
Daxocox
|
140 mg
|
EU/2/21/270/037
|
Ecuphar NV, Beļģija
|
QM01AH95
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Enflicoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
02-Aug-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/270/037 |
|
1 |
Blisteris, 5 tablete |
-
|
|
|
Forceris
|
-
|
EU/2/19/235/001
|
Ceva Sante Animale,, Francija
|
QP51BC01
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Toltrazuril, Iron III
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale,, Francija
|
| Date of authorisation/renewal: |
05-Jul-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/235/001 |
30 mg/133 mg |
1 |
Plastikāta flakons, 100 ml |
-
|
|
|
Coxatab
|
100 mg
|
EU/2/22/286/018
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
| Date of authorisation/renewal: |
12-Aug-2022
|
| Marketing authorisation valid until: |
11-Aug-2027
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/286/018 |
100 mg/tabl. |
1 |
alumīnija/PVC/PE/PVDC blisteris, 200 tablete |
-
|
|
|
Lotilaner/Milbemycin Elanco 450 mg/16,88 mg
|
-
|
EU/2/26/361/014
|
Elanco GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
25-Feb-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/361/014 |
|
3 |
Al/Al blisteris, 1 tablete |
-
|
|
|
Chanhold
|
30 mg
|
EU/2/19/236/008
|
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
QP54AA05
|
dogs 2,6 - 5,0 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
17-Apr-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/236/008 |
120 mg/ml |
6 |
Plastmasas pipete, 0,25 ml |
-
|
|
|
BRAVECTO CombiUNO
|
-
|
EU/2/25/350/013
|
Intervet International B.V., Nīderlande
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Fluralaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
30-Jul-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/350/013 |
|
1 |
Blisteris, 1 tablete |
-
|
|
|
Ingelvac CircoFLEX
|
-
|
EU/2/07/079/015
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI09AA07
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated recombinant Porcine Circovirus type 2
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
| Date of authorisation/renewal: |
13-Apr-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/07/079/015 |
|
12 |
TwistPak pudele, 100 ml |
-
|
|
|
Versican Plus Pi/L4
|
-
|
EU/2/14/172/002
|
Zoetis Belgium S.A., Beļģija
|
QI07AI08
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Canine Parainfluenza Type 2 virus, strain CPiV2-Bio15,Inactivated Leptospira interrogans serovar Canicola, strain MSLB 1090,Leptospira kirschneri serovar Grippotyphosa, strain MSLB 1091,Leptospira interrogans serovar Icterohaemorrhagia, strain MSLB 1089
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
27-Oct-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/172/002 |
|
50 |
Stikla flakons, 1 deva |
-
|
|
|
EVICTO
|
15 mg
|
EU/2/19/242/003
|
VIRBAC, Francija
|
QP54AA05
|
cats ≤ 2,5 kg; dogs ≤ 2,5 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
VIRBAC, Francija
|
| Date of authorisation/renewal: |
19-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/242/003 |
60 mg/ml |
24 |
Polipropilēna pipete, 0,25 ml |
-
|
|
|
Tulaven
|
25 mg/ml
|
EU/2/20/251/006
|
Ceva Sante Animale,, Francija
|
QJ01FA94
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tulathromycin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale,, Francija
|
| Date of authorisation/renewal: |
24-Apr-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/251/006 |
|
1 |
Plastmasas flakons, 50 ml |
-
|
|
|
Reconcile
|
8 mg
|
EU/2/08/080/001
|
FORTE Healthcare Limited, Īrija
|
QN06AB03
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Fluoxetine hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Eli Lilly and Company Limited, Lielbritānija
|
| Date of authorisation/renewal: |
13-Jul-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/080/001 |
8 mg/tabl. |
30 |
ABPE pudele, 1 tablete |
-
|
|
|
Trilocur
|
50 mg/ml
|
EU/2/24/312/005
|
Emdoka bvba, Beļģija
|
QH02CA01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Trilostane
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
06-May-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/312/005 |
50 mg/ml |
1 |
Kartona kastīte, 36 ml |
-
|
|
|
Credelio
|
112 mg
|
EU/2/17/206/005
|
Elanco GmbH, Vācija
|
QP53BE04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
26-Apr-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/206/005 |
112 mg |
1 |
Alumīnija blisteris, 3 tablete |
-
|
|
|
Purevax RCP FeLV
|
-
|
EU/2/04/048/003
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI06AJ03
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Recombinant Canarypox virus,Attenuated feline rhinotracheitis herpesvirus,Inactivated feline panleucopenia virus,Inactivated feline Calicivirosis antigens
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial Laboratory of Lyon Porte des Alpes, Francija
|
| Date of authorisation/renewal: |
23-Feb-2005
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| -01 |
1 devas/flakonā |
10 |
Stikla pudelīte, 1 deva |
-
|
|
|
Prevestrus vet
|
100 mg/tabl.
|
EU/2/25/338/009
|
Vetcare Oy, Somija
|
-
|
dogs (bitches)
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
film-coated tablets
|
| International name (active substance): |
Finrozole
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
23-Apr-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/338/009 |
|
1 |
Blisteris, 7 tablete |
-
|
|
|
Simparica Trio
|
mg
|
EU/2/19/243/001
|
Zoetis Belgium S.A., Beļģija
|
QP54AB52
|
Dogs 1,25 – 2,5 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Sarolaner, Moxidectin, Pyrantel embonate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Corden Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
17-Sep-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/243/001 |
|
1 |
Alumīnija folija blisteris, 1 tablete |
-
|
|
|
Ypozane
|
3.75 mg
|
EU/2/06/068/002
|
Virbac S.A., Francija
|
QG04CX
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Osaterone acetate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
11-Jan-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/06/068/002 |
3,75 mg |
1 |
Alumīnija blisteris, 7 tablete |
-
|
|
|
Cimalgex
|
80 mg
|
EU/2/10/119/010
|
Vetoquinol S.A., Francija
|
QM01AH93
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Cimicoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
07-Jan-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/10/119/010 |
80 mg |
4 |
Blisteris, 8 tablete |
-
|
|
|
ReproCyc ParvoFLEX
|
-
|
EU/2/19/237/003
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI09AA02
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Porcine Parvovirus strain 27a VP2 subunit antigen
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
| Date of authorisation/renewal: |
26-Apr-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/237/003 |
|
1 |
ABPE pudele, 200 ml/100 deva |
-
|
|